Alkem Laboratories Ltd.
₹5,639.5-1.96%Feb 27, 3:45 PM IST
ALKEM•Health Technology•Pharmaceuticals: Major
Current Price
₹5,639.5-1.96%
Feb 27, 3:45 PM ISTMarket Cap₹68,758.84 Cr
Market Cap₹68,758.84 Cr
Business Overview
Alkem Laboratories Limited operates through 5 main business divisions including India Business, International Business, Enzene Biosciences (Subsidiary), Active Pharmaceutical Ingredients (API) Business, Strategic Growth Areas.
Business Hierarchy Structure for Alkem Laboratories Limited
- Alkem Laboratories Limited
- India Business
- Acute Therapies
- Anti-infectives
- Gastro-intestinal
- Pain Management
- Vitamins/Minerals/Nutrients (VMN)
- Flagship Brands
- Clavam
- Pan
- Pan D
- A to Z
- Uprise D3
- Taxim-O
- Chronic Therapies
- Anti-diabetic
- Cardiac
- Derma
- Neuro/CNS
- Respiratory
- Ophthalmology
- Eye Care Products
- Trade Generics
- Acute Therapies
- International Business
- US Business
- Non-US Markets
- LATAM
- Europe
- Enzene Biosciences (Subsidiary)
- Biosimilars
- Cetuxa
- Ranibizumab
- Contract Development and Manufacturing Organization (CDMO)
- US CDMO Operations
- Biosimilars
- Active Pharmaceutical Ingredients (API) Business
- Alkem Activa
- Strategic Growth Areas
- Medical Devices Sector
- Over-the-Counter (OTC) Category
- India Business